Sphingosine 1-Phosphate (S1P) in the Peritoneal Fluid Skews M2 Macrophage and Contributes to the Development of Endometriosis
Authors:
- Yosuke OnoYOYosuke Ono
- Takako KawakitaTKTakako Kawakita
- Osamu YoshinoOsamu Yoshino
- Erina SatoESErina Sato
- Kuniyuki KanoKKKuniyuki Kano
- Mai OhbaMOMai Ohba
- Toshiaki OkunoTOToshiaki Okuno
- Masami ItoMIMasami Ito
- Kaori KogaKKKaori Koga
- Masako HondaMHMasako Honda
- Akiko FurueAFAkiko Furue
- Takehiro HiraokaTHTakehiro Hiraoka
Open Access
- 22 October 2021
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 9 (11) , 1519
Abstract
Sphingosine 1-phosphate (S1P), an inflammatory mediator, is abundantly contained in red blood cells and platelets. We hypothesized that the S1P concentration in the peritoneal cavity would increase especially during the menstrual phase due to the reflux of menstrual blood, and investigated the S1P concentration in the human peritoneal fluid (PF) from 14 non-endometriosis and 19 endometriosis patients. Although the relatively small number of samples requires caution in interpreting the results, S1P concentration in the PF during the menstrual phase was predominantly increased compared to the non-menstrual phase, regardless of the presence or absence of endometriosis. During the non-menstrual phase, patients with endometriosis showed a significant increase in S1P concentration compared to controls. In vitro experiments using human intra-peritoneal macrophages (MΦ) showed that S1P stimulation biased them toward an M2MΦ-dominant condition and increased the expression of IL-6 and COX-2. An in vivo study showed that administration of S1P increased the size of the endometriotic-like lesion in a mouse model of endometriosis.Keywords
Funding Information
- Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (19K09823)
This publication has 31 references indexed in Scilit:
- Endometriosis, a disease of the macrophageFrontiers in Immunology, 2013
- NET balancing: a problem in inflammatory lung diseasesFrontiers in Immunology, 2013
- The outs and the ins of sphingosine-1-phosphate in immunityNature Reviews Immunology, 2011
- Lymphocytes in EndometriosisAmerican Journal of Reproductive Immunology, 2010
- Inhibition of CD36-Dependent Phagocytosis by Prostaglandin E2 Contributes to the Development of EndometriosisThe American Journal of Pathology, 2010
- Macrophages Are Alternatively Activated in Patients with Endometriosis and Required for Growth and Vascularization of Lesions in a Mouse Model of DiseaseThe American Journal of Pathology, 2009
- FR 167653, a p38 mitogen-activated protein kinase inhibitor, suppresses the development of endometriosis in a murine modelJournal of Reproductive Immunology, 2006
- Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineagesCancer Cell, 2006
- Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine modelFertility and Sterility, 2005
- Possible Pathophysiological Roles of Mitogen‐Activated Protein Kinases (MAPKs) in EndometriosisAmerican Journal of Reproductive Immunology, 2004